Lanean...
CSF biomarkers of Alzheimer disease: “Noncognitive” outcomes
OBJECTIVES: To test whether CSF Alzheimer disease biomarkers (β-amyloid 42 [Aβ(42)], tau, phosphorylated tau at threonine 181 [ptau(181)], tau/Aβ(42), and ptau(181)/Aβ(42)) predict future decline in noncognitive outcomes among individuals cognitively normal at baseline. METHODS: Longitudinal data fr...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Lippincott Williams & Wilkins
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854826/ https://ncbi.nlm.nih.gov/pubmed/24212387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/01.wnl.0000436940.78152.05 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|